Testing effectiveness (Phase 2)Study completedNCT04849416
What this trial is testing
LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)
Who this might be right for
Leukemia, LymphoidLymphoma, Non-HodgkinLymphoma, Mantle-Cell+4 more
Eli Lilly and Company 87